<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04573127</url>
  </required_header>
  <id_info>
    <org_study_id>2020PI159</org_study_id>
    <nct_id>NCT04573127</nct_id>
  </id_info>
  <brief_title>Gender Dysphoria: Epidemiological Data</brief_title>
  <acronym>DyGenEpi</acronym>
  <official_title>Epidemiological Characteristics of the Population of Persons With Gender Dysphoria : Data From the Cohort Follow-up in CHRU de Nancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective study in a single academic regional transgender referral center. data from the&#xD;
      cohort follow-up in CHRU de Nancy&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 27, 2020</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incdience rate of cardiovascular diseases</measure>
    <time_frame>2004-2020</time_frame>
    <description>Number of new cases of arterial hypertension, stroke, myocardial infarction during the specified period (2004-2020) /Time each person was observed, totaled for all persons</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence rate of dyslipidemia</measure>
    <time_frame>2004-2020</time_frame>
    <description>Number of new cases of dyslipidemia during the specified period (2004-2020) /Time each person was observed, totaled for all persons</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence rate of oncological diseases</measure>
    <time_frame>2004-2020</time_frame>
    <description>Number of new cases of malignancies during the specified period (2004-2020) /Time each person was observed, totaled for all persons</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence rate of psychiatric diseases</measure>
    <time_frame>2004-2020</time_frame>
    <description>Number of new cases of psychiatric diseases malignancies during the specified period (2004-2020) /Time each person was observed, totaled for all persons</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall mortality rate</measure>
    <time_frame>2004-2020</time_frame>
    <description>Mortality during the specified period (2004-2020) /Time each person was observed, totaled for all persons</description>
  </secondary_outcome>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Gender Dysphoria</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>descriptive study</intervention_name>
    <description>Retrospective analysis of existing data collected as a part of the regular follow-up</description>
    <other_name>Retrospective analysis of existing data collected as a part of the regular follow-up</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who met diagnostic criteria for gender dysphoria (International Classification of&#xD;
        Diseases 11th Revision. https://icdwhoint. 2018) and were seen regularly in the outpatient&#xD;
        clinic at our department of endocrinology&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Retrospective analysis of available data as a part of the regular care of subjects with&#xD;
        gender dysphoria. All measurements were made at the time of the routine follow-up visits&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Subjects who met diagnostic criteria for gender dysphoria (International Classification of Diseases 11th Revision. https://icdwhoint. 2018) and were seen regularly in the outpatient clinic at our department of endocrinology</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHRU Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 7, 2020</study_first_submitted>
  <study_first_submitted_qc>September 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2020</study_first_posted>
  <last_update_submitted>September 28, 2020</last_update_submitted>
  <last_update_submitted_qc>September 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder, Major</mesh_term>
    <mesh_term>Gender Dysphoria</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

